Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Takeda Pharmaceutical Co Ltd의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Takeda Pharmaceutical Co Ltd 주요 수익원은 Gastroenterology Revenue (Pre-FY2023 Reporting)이며, 최신 수익 발표에서 수익은 1,216,207,000,000입니다. 지역별로는 Japan이 Takeda Pharmaceutical Co Ltd의 주요 시장이며, 수익은 433,110,000,000입니다.
Takeda Pharmaceutical Co Ltd은 수익성이 있나요?
no, 최신 재무제표에 따르면 Takeda Pharmaceutical Co Ltd의 순손실은 $0입니다.